Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, Penny Traders Club, Top Penny, bz777, UndervaluedStocks, HighYieldStocks
Search This Board: 
Last Post: 6/29/2017 10:03:40 AM - Followers: 400 - Board type: Free - Posts Today: 7



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#46897  Sticky Note ARYC is a Silicon Valley company that is UndervaluedStocks 06/07/17 02:40:15 PM
#46478  Sticky Note We expect an immediate share price increase upon techmover 05/25/17 05:24:04 PM
#45708  Sticky Note NEW...Arrayit to double manufacturing capacity by 6/30/2017 to HighYieldStocks 05/08/17 11:49:19 AM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#41045  Sticky Note Here are the details and DD updates StockZoom 02/08/17 10:32:34 AM
#47724   Bring the volatility,stock above $0.10 is a dream. jdemuss 06/29/17 10:18:54 AM
#47723   3 years had to be audited .... and UndervaluedStocks 06/29/17 10:03:40 AM
#47722   But you're right in that most things that bz777 06/29/17 10:03:19 AM
#47721   Takes extra time to go back and audit bz777 06/29/17 10:02:03 AM
#47720   Thank you PJ. I've done my DD on UndervaluedStocks 06/29/17 10:01:26 AM
#47719   If it sounds too good to be true, JEck017 06/29/17 09:55:59 AM
#47718   Undervalued you have been the voice of reason Pokerjoe 06/29/17 09:55:24 AM
#47717   There are many who are watching this company. UndervaluedStocks 06/28/17 10:08:44 PM
#47716   can't argue that whento 06/28/17 10:00:13 PM
#47715   I'll take .25 anytime kittie88 06/28/17 09:53:44 PM
#47714   Moving up the breakout board...feeling something warm and ROSECITY 06/28/17 09:33:51 PM
#47713   Once the financials are out and they remove Penny Traders Club 06/28/17 08:22:55 PM
#47712   Aryc web news today: lots of eyes on Ken1998 06/28/17 08:14:50 PM
#47711   Aryc barchart opinion: 100%buy for short, medium and Ken1998 06/28/17 08:11:03 PM
#47710   Grab them cheapies before its to late!!! Penny Traders Club 06/28/17 08:00:44 PM
#47709   Nice day today! Top Penny 06/28/17 06:54:06 PM
#47708   I would agree, Penny Traders Club 06/28/17 05:23:26 PM
#47707   Thanks! Liuhisn 06/28/17 05:18:00 PM
#47706   Thanks Liuhisn 06/28/17 05:17:32 PM
#47705   I was going to defer to those board whento 06/28/17 05:05:32 PM
#47704   Quite possibly .40 and as high as $1.00+ techmover 06/28/17 04:46:24 PM
#47703   Revenues of $40k+ per day..... ARYC is trading UndervaluedStocks 06/28/17 04:43:23 PM
#47702   New to the board. How high is this Liuhisn 06/28/17 04:40:36 PM
#47701   HAHA. Of course. your right! whento 06/28/17 04:21:47 PM
#47700   yes, that's why he's willing to pay it. bz777 06/28/17 04:07:47 PM
#47699   next year? we should be well past that whento 06/28/17 04:04:47 PM
#47698   Next year I'll take you up on that UndervaluedStocks 06/28/17 04:00:31 PM
#47697   for a .25 whento 06/28/17 03:59:34 PM
#47696   I love this positve board action...awesome HighYieldStocks 06/28/17 03:57:41 PM
#47695   375k up at the bid.....anyone??? Anyone??? UndervaluedStocks 06/28/17 03:57:37 PM
#47694   I'm sitting just under the Bid hoping for UndervaluedStocks 06/28/17 03:56:31 PM
#47693   Yeah really, those guys are going to be techmover 06/28/17 03:55:09 PM
#47692   The next few days will be crazy collecting days Penny Traders Club 06/28/17 03:54:58 PM
#47691   ARYC will go through the roof...everything fits together perfectly HighYieldStocks 06/28/17 03:54:06 PM
#47690   Investors who really want shares, imo, shouldnt let whento 06/28/17 03:53:37 PM
#47689   Sounds like a Final STEP! glory2000 06/28/17 03:50:35 PM
#47688   I'd like to express my sincere condolences to UndervaluedStocks 06/28/17 03:49:17 PM
#47687   Now THAT sounds like excellent news!!! techmover 06/28/17 03:25:51 PM
#47686   Arrayit provides all current outstanding items for audit Penny Traders Club 06/28/17 03:05:58 PM
#47685   Sounds good, bring it on lol bz777 06/28/17 03:05:16 PM
#47684   NEW...Arrayit provides all current outstanding items for audit HighYieldStocks 06/28/17 02:51:00 PM
#47683   Overall Average up to 88% Buy HighYieldStocks 06/28/17 02:44:49 PM
#47682   Arrayit reports $28,000 microarray services sale to a UndervaluedStocks 06/28/17 01:51:25 PM
#47681   NEW...Arrayit reports microarray technology sale to top medical HighYieldStocks 06/28/17 01:09:15 PM
#47680   NEW...Arrayit reports microarray instrument inquiry from top scientist HighYieldStocks 06/28/17 01:09:10 PM
#47679   NEW...Arrayit reports $46,000 microarray instrument inquiry from leadi HighYieldStocks 06/28/17 01:07:47 PM
#47678   NEW...Arrayit reports $47,700 microarray services sale to top HighYieldStocks 06/28/17 01:07:12 PM
#47677   Almost $100k in sales today....ARYC UndervaluedStocks 06/28/17 01:06:25 PM
#47676   NEW...Arrayit reports $36,000 microarray services sale to a HighYieldStocks 06/28/17 01:06:23 PM
#47675   NEW...Arrayit reports microarray technology sale to biomedical researc HighYieldStocks 06/28/17 01:06:18 PM